William R Miller

39PUBLICATIONS
46CO-AUTHORS
Medical infection agents (incl. prions)Intensive careMicrobial geneticsMajor global burdens of diseaseReceptors and membrane biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 15, 2026
Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.

|Feb 12, 2026
Loss of the ferripyochelin receptor FptA drives reduced cefiderocol susceptibility and impairs fitness in Pseudomonas aeruginosa PA14.

Donghoon Kang, Rodrigo P Baptista, Salvador I Drusin

|Nov 07, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE).

Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo

|Sep 26, 2025
Loss of the Ferripyochelin Receptor FptA Drives Reduced Cefiderocol Susceptibility and Impairs Fitness in Pseudomonas aeruginosa PA14.

Donghoon Kang, Rodrigo P Baptista, Cesar A Arias

|Sep 22, 2025
Pharmacokinetics of sulbactam-durlobactam in patients with Acinetobacter baumannii ventriculitis: a report of two cases.

Nazanin Pouya, Natalie A Finch, Alejandro Granillo

|Sep 11, 2025
Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections.

Adrianna M Turner, Paul Kinsella, William R Miller

Pageof 7

Frequent Collaborators

13 joint publications

Cesar A Arias

8 joint publications

Blake M Hanson

8 joint publications

Truc T Tran

6 joint publications

Jinnethe Reyes